Neonatal testosterone treatment of female rats led to an increase in body weight and skeletal growth and produced evidence of altered ovarian function over a 76 day period following treatment. Bilateral ovariectomy performed eleven weeks after neonatal treatment increased the rate of body weight gain of both testosterone propionate-and oil-treated groups, but no differences in the increased rates of weight gain were evident between groups over a five week post-ovex observation period. Subse¬ quently, long-term oestrogen replacement therapy, via subcutaneous Silastic implants, produced equal reductions in the rates of body weight gain and somatic growth of both early testosterone-and oil-treated ovariecto¬ mized groups. In spite of the marked effects of these manipulations on body weight and skeletal growth, no significant differences were noted in the Lee Index of obesity between androgenized and the appropriate nonandrogenized control rats at any interval of the experimental period.
ment at the follicular stage (Barraclough 1961; Harris 1964; Harris 8c Levine 1965) . In addition, the perinatally androgenized female rat exhibits a higher rate of growth and attains a mature body weight well above the untreated control animal (Beatty et al. 1970; Bell 8c Zucker 1971; Swanson 8c van der Wer ff ten Bosch 1963) .
Recently a number of investigators have proposed that circulating oestradiol levels contribute to the generation of a 'set point' signal necessary for the normal regulation of body weight in female rats (Mook et al. 1972; Redick et al. 1973; Zucker 1972) . This research has demonstrated that a reduction in the level of endogenous oestrogen (e. g., by bilateral ovariectomy) causes an immediate in¬ crease in food intake and rate of weight gain that culminates in 'obesity'. In contrast, if oestradiol benzoate (OeB) treatment is begun simultaneously with ovariectomy, no alteration in long-term body weight regulation occurs (Tarttelin 8c Gorski 1973; Dubuc 1974) . Additionally, if after ovariectomy 'obesity' is allowed to develop, OeB replacement therapy will lead to a reduction in the rate of weight gain until the body weight approaches the level of the intact control rat (Dubuc 1974) .
As noted earlier, perinatal testosterone treatment results in altered ovarian function and the maintenance of an increased rate of body weight gain. It is possible that the body weight effects of early testosterone treatment are mediated by either a decrease in endogenous oestrogen production or by a decreased sensitivity of oestrogen receptors that govern the level at which body weight is regulated. To explore these possibilities the following study examined the participation of the ovary and ovarian hormones in the altered body weight regulation of female rats following perinatal androgen treatment.
MATERIALS AND METHODS
The experimental animals were the first generation offspring of Sprague-Dawley rats (Horton Labs, Oakland, California) (Dubuc 1974) ) Body weight (g) 1/3 103 Naso-anus length (cm) (Fig. 2) . Again, no differences between TP-or oil-treated groups were apparent over this nine week sham implant period (F = 0.37, 3 and 16 df, P > 0.05; multivariate profile analysis). OeB treatment following ovariectomy, in addition to reducing the rate of body weight gain, led to a significant reduction in skeletal growth over the post-ovex period of both early TP-and oil-treated groups ( Table 2 ). The Lee Index of obesity, although generally lower in the OeB treated animals of both major experimental groups, was not significantly different between any sub-group pair. Additionally, no differences were noted in the Lee Index at sacrifice between combined OeB-treated (early TP-and early oil-) vs. combined shamtreated sub-groups (P > 0.05, Student's t), suggesting a relatively insignificant effect of OeB replacement therapy on 'obesity' as defined by the Lee Index. However, it should be noted that the early TP-treated group, by virtue of their increased rate of weight gain in Part I, had a higher absolute body weight when OeB treatment was begun. Since the capsules used in the present study were identical for both the TP-treated and oil-treated groups, these weight differences resulted in the administration of a slightly lower dose (per unit body weight) of OeB to the TP-treated animals. It appears, however, that these small differences in dose between groups were of little importance since the TP-treated animals were, if anything, more sensitive to the weight depressing effects of OeB (Fig. 2) . The slightly increased sensitivity to OeB noted in this group may reflect the higher pre-treatment weight, as OeB's effectiveness to reduce body weight has been shown to be inversely related to the pre-treatment weight (Mook et al. 1972; Redick et al. 1973; Zucker 1972; Dubuc 1974 Previous studies have shown that oestrogen treatment following ovariectomy depresses the rate of body weight gain in the post-ovex period (Mook et al. 1972; Redick et al. 1973; Tarttelin 8c Gorski 1973; Zucker 1972; Dubuc 1974 ) and the effect is approximately proportional to the level of 'obesity' that is allowed to develop following ovariectomy (Dubuc 1974 (Kurcz et al. 1968 ). However, the potential role of GH in mediating the increased body weight and growth of the early androgen syndrome requires further investigation.
